Blood dilution technique for bone cancer surgery
Part of Cancer clinical trials.
This trial tests a method called acute normovolemic hemodilution, where some blood is removed before surgery and replaced with fluids, then given back to you after surgery. It may reduce the need for donor blood transfusions during bone cancer surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for surgery to remove a bone cancer tumor.
- Your hemoglobin level is 12 g/dL or higher (a blood test measures this).
- You weigh between 50 and 100 kilograms (about 110 to 220 pounds).
- You do not have active infections or severe heart, lung, liver, or kidney problems.
- You are not pregnant and you are willing to accept blood transfusions if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a technique called 'acute normovolemic hemodilution' during bone tumor surgery. It involves temporarily thinning your blood by removing some red blood cells and replacing them with fluid, which may reduce the need for blood transfusions.
This study tests whether a technique that thins your blood during surgery can help people having bone tumor removal. It may reduce the need for blood transfusions.
This trial is testing a special fluid called succinylated gelatin (a type of colloid) given during surgery to help maintain blood volume. It is for people having planned surgery lasting less than 6 hours and who are in generally good health, without major heart, liver, or kidney problems.
This study tests a solution called succinylated gelatin, given during surgery to maintain blood volume. It aims to see if it is effective and safe for adults having planned operations that last less than six hours.
This trial tests if removing some blood before surgery and replacing it with fluids can reduce the need for transfusions in people with advanced ovarian cancer. It may help you have less blood loss during your operation.
This trial tests a personalized approach to managing your own blood during surgery, which may reduce the need for donor blood transfusions. It is for people having planned non-cardiac surgery expected to need a large amount of blood.
Hear when a new Acute Normovolemic Hemodilution trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.